glp 1 inhibitor drugs Glucagon-like peptide-1 The Role of GLP-1, DPP-4,
Description
Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.
Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity
The key takeaway
GLP-1 is a peptide hormone secreted by L cells in the ileum and colon
